Results 101 to 110 of about 49,567 (304)

Clinical Outcomes and Patient Experiences With Celiprolol Therapy in Vascular Ehlers–Danlos Syndrome: The First Non‐European Cohort

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Vascular Ehlers–Danlos syndrome (vEDS) is a hereditary connective tissue disorder caused by heterozygous pathogenic variants in COL3A1. European studies have shown that celiprolol may reduce the risk of life‐threatening vascular events, but outcomes in non‐European populations and the therapy's psychological impact remain unclear. We conducted
Megumi Furuhata‐Yoshimura   +2 more
wiley   +1 more source

Small Bowel Obstruction due to Anomalous Congenital Bands in Children

open access: yesGastroenterology Research and Practice, 2016
Introduction. The aim of the study was to evaluate our children who are operated on for anomalous congenital band while increasing the awareness of this rare reason of intestinal obstruction in children which causes a diagnostic challenge.
Basak Erginel   +6 more
doaj   +1 more source

A microscopically assisted limited colectomy mouse model of early colon cancer

open access: yesAnimal Models and Experimental Medicine, EarlyView.
Establishment, surgery, and evaluation process of a microscope‐assisted limited colon resection mouse model for early‐stage colon cancer. Abstract Background Currently, there is a lack of an adequate rodent model for investigating surgical techniques and comprehensive treatment options for patients with colorectal cancer (CRC).
Yu Han   +3 more
wiley   +1 more source

Successful Non-Operative Management of Middle Colic Artery Injury Using Transcatheter Arterial Embolization Performed in a Hybrid Emergency Room System [PDF]

open access: yesJournal of Acute Care Surgery
Mesenteric injuries from blunt trauma are rare, but can result in life-threatening complications, including massive hemorrhage from mesenteric arterial disruption, bowel ischemia, necrosis, and perforation.
Joo Hyun Lee   +3 more
doaj   +1 more source

Ascites Drainage Leading to Intestinal Adhesions at the Mesentery of the Small Intestine with Fatal Outcome

open access: yes, 2014
A common problem in patients with chronic liver diseases and liver cirrhosis is the development of ascites. First line therapy for ascites is the restriction of sodium intake and a diuretic treatment.
G. Grannas   +3 more
core   +1 more source

A novel mouse model of endometriosis: Simulating the recurrent hemorrhagic microenvironment of clinical lesions

open access: yesAnimal Models and Experimental Medicine, EarlyView.
To address the limitations of existing models, this study innovatively established a mouse model of endometriosis (EMs) capable of mimicking cyclic bleeding. Our results confirmed that this model recapitulates the complete pathological progression from ectopic lesion establishment to systemic responses, exhibiting superior clinical relevance compared ...
Yu Zhuang   +7 more
wiley   +1 more source

Ultrasonic Manifestations of Mesenteric Inflammatory Myofibroblastic Tumors in Children

open access: yesFrontiers in Pediatrics, 2019
Objective: To explore the ultrasonic manifestations of mesenteric inflammatory myofibroblastic tumors (IMTs) in children.Methods: Seven patients with mesenteric IMTs were retrospectively analyzed.
Jingjing Qian, Kun Zhu, Jingjing Ye
doaj   +1 more source

Small bowel mesentery solitary fibrous tumor. A rare neoplasia in a young male [PDF]

open access: yes, 2012
Extrapleural Solitary Fibrous Tumors (SFT), in particular small bowel mesentery SFTs, are extremely rare neoplasms. We describe the case of a young male hospitalized for unspecific abdominal symptoms and evidence of a well-circumscribed mass arising ...
Donini, Annibale   +3 more
core  

Mucinous Cystic Borderline Tumor of the Mesentery: A Case Report

open access: yes, 2017
Mucinous cystic neoplasms are rare tumors of uncertain histogenesis. They arise from the ovaries, pancreas, and other intra-abdominal sites but more unusually from the mesentery.
R. Poudel   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy